R&D Strategy & Pipeline

R&D Strategy & Pipeline

R&D Strategy & Pipeline

Committed to innovation, Da Volterra develops microbiota protecting therapies as well as tools intended to harness potential to help prevent and cure human diseases.

Over the years since inception, we have gathered a unique in-house expertise on the intestinal microbiota and its links to the different body functions, antibacterial drugs and other drugs disrupting the microbiota as well as drug delivery technologies.